HD-OPM Archive
Topics › Statins

Statin use linked to 20% lower dementia and 32% lower Alzheimer's risk in meta-analysis

Louis Nervegna · Oct 22, 2024 · ♥ 19 reactions · 1 comments · original Facebook post
StatinsBrain health & dementia
AI summary & key facts

Louis cites a systematic review and meta-analysis of observational studies. Statin use was linked to a lower risk of dementia (36 studies) and Alzheimer's disease (21 studies), which the authors say confirms no neurocognitive risk and hints at a possible benefit. They call for dedicated randomized trials.

In a huge meta-analysis of observational studies, statin use was associated with a 20% lower risk of dementia (36 studies), and a 32% lower risk of Alzheimer’s (21 studies).

Quoted:

“In the pooled analyses, statins were associated with a decreased risk of dementia [36 studies, OR 0.80 (CI 0.75–0.86)] and of AD [21 studies, OR 0.68 (CI 0.56–0.81)].”

“These results confirm the absence of a neurocognitive risk associated with statin treatment and suggest a potential favourable role of statins. Randomized clinical trials with an ad hoc design are needed to explore this potential neuroprotective effect.”

#statinsdementiaHD #ldldementiaHD #statinsHD #dementiaHD #alzheimersHD

Paper · Eur J Preventive CardiologyEur J Preventive Cardiology articleAbstractAims. As the potential impact of statins on cognitive decline and dementia is still debated, we conducted a meta-analysis of observational studiesacademic.oup.com

Research cited

← newer: Mayo Clinic study: skin generates senescent cells that may aolder: Chiropractor had a widow-maker heart attack at 35 with CAC 0 →